Class II
Drug Recall: EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.
Mckesson Medical-Surgical Inc. Corporate Office · April 21, 2025
Reason for Recall
CGMP Deviations; potential temperature excursions due to transit delays
Distribution
Within the U.S - OH, VA, FL.
States Affected
FL, OH, VA
Quantity Affected
2 Pre-filled syringes
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0539-2025
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.